Grey Wolf Therapeutics Programs

About Xlife Sciences

Xlife Sciences AG is a publicly traded Swiss biotech company that identifies, develops, and commercializes promising biomedical innovations. Its strategy involves in-licensing early-stage projects, providing funding and operational support to advance them, and ultimately realizing value through partnerships, spin-offs, or direct commercialization. The company's diversified portfolio spans therapeutics, diagnostics, and research tools, with a focus on high-value assets in oncology, immunology, and other areas of significant unmet medical need.

Therapeutic Areas